Azenta, Inc. AZTA 深滬

等待開盤 05-19 09:30:00 美东时间

16.37

+0.350

+2.18%

華盛通

立即下載

最高16.71
今開16.12
成交量 68.26万股
最低 15.93
昨收 16.02
總市值 7.55亿
52周最高 41.73
市盈率 ^靜 --
換手率 1.48%
52周最低 15.93
委比 -97.92%
總股本 4609.28万
歷史最高 124.69
量比 0.97
振幅 4.87%
歷史最低 3.92
每手 1
風險率 4.97%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价

今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元

05-07 12:37
Needham Maintains Buy on Azenta, Lowers Price Target to $33

Needham analyst David Saxon maintains Azenta (NASDAQ:AZTA) with a Buy and lowers the price target from $44 to $33.

05-07 04:08
12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...

05-07 01:05
Azenta shares are trading lower after the company reported worse-than-expected Q2 financial results and issued FY26 sales guidance below estimates.

Azenta shares are trading lower after the company reported worse-than-expected ...

05-06 22:29
财报速睇 | Azenta, Inc. 2026财年Q1营收1.45亿美元，同比增长1.0%；归母净利润亏损1.57亿美元，同比亏损扩大693.4%

华盛资讯5月6日讯，Azenta, Inc.公布2026财年Q1业绩，公司Q1营收1.45亿美元，同比增长1.0%，归母净利润亏损1.57亿美元，同比亏损扩大693.4%。

05-06 07:09
Azenta Sees FY2026 Sales $603.000M-$621.000M vs $623.837M Est

Azenta (NASDAQ:AZTA) sees FY2026 sales of $603.000 million-$621.000 million vs $623.837 million analyst estimate.

05-06 05:43
Azenta Q2 Adj. EPS $0.08 Misses $0.12 Estimate, Sales $145.000M Miss $148.740M Estimate

Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.12 by 33.33 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same

05-06 05:07
Azenta (AZTA) Stock Drops 13% After-Hours — What's Happening?

Azenta stock falls after-hours following SEC Form 3 filing showing no beneficial ownership.

04-17 13:46
12 Health Care Stocks Moving In Thursday's After-Market Session

Gainers Psyence Biomedical (NASDAQ:PBM) shares increased by 63.4% to $9.59 dur...

04-17 05:05
美股大行评级 | 目标价31美元，潜在涨幅64%！多家大行首予PayPay"买入"评级；大摩上调希捷科技目标价从468美元升至582美元

今日重点评级关注：Canaccord Genuity：维持Taysha Gene Therapies"买入"评级，目标价从14美元升至17美元；Guggenheim：维持天演药业"买入"评级，目标价从9美元升至10美元

04-07 11:53

派息除權日	每股總股息	派息日期
2021-12-02	0.10	2021-12-23
2021-09-02	0.10	2021-09-24
2021-06-03	0.10	2021-06-25
2021-03-04	0.10	2021-03-26
2020-12-03	0.10	2020-12-17
2020-09-03	0.10	2020-09-25
2020-06-04	0.10	2020-06-26
2020-03-05	0.10	2020-03-27
2019-12-05	0.10	2019-12-20
2019-09-05	0.10	2019-09-27
2019-06-06	0.10	2019-06-28
2019-02-28	0.10	2019-03-22
2018-12-06	0.10	2018-12-20
2018-09-06	0.10	2018-09-28
2018-05-31	0.10	2018-06-22
2018-03-01	0.10	2018-03-23
2017-11-30	0.10	2017-12-22
2017-09-07	0.10	2017-09-29
2017-05-31	0.10	2017-06-23
2017-03-01	0.10	2017-03-24
2016-11-30	0.10	2016-12-23
2016-08-31	0.10	2016-09-23
2016-06-01	0.10	2016-06-24
2016-03-02	0.10	2016-03-24
2015-12-02	0.10	2015-12-22
2015-09-02	0.10	2015-09-25
2015-06-03	0.10	2015-06-26
2015-03-04	0.10	2015-03-27
2014-12-03	0.10	2014-12-26
2014-09-03	0.10	2014-09-26
2014-06-04	0.08	2014-06-27
2014-03-05	0.08	2014-03-28
2013-12-04	0.08	2013-12-27
2013-09-04	0.08	2013-09-27
2013-06-05	0.08	2013-06-28
2013-03-06	0.08	2013-03-29
2012-12-05	0.08	2012-12-28
2012-09-05	0.08	2012-09-28
2012-06-06	0.08	2012-06-29
2012-03-07	0.08	2012-03-30
2011-12-07	0.08	2011-12-30
2011-09-07	0.08	2011-09-30

公司名稱	Azenta, Inc.
行業分類	Medical/Nursing Services
業務描述	Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Azenta, Inc. AZTA 深 滬

16.37

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Azenta, Inc. AZTA 深滬